Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-06-30

FDA Approved: PHENYTOIN SODIUM — Original Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approves Sun Pharmaceutical's Phenytoin Sodium as an oral generic anticonvulsant indicated for the control of seizures in epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PHENYTOIN SODIUM (phenytoin sodium)

Snippet

ORIG AP for PHENYTOIN SODIUM (PHENYTOIN SODIUM)